🌎 Arrowhead Pharmaceuticals Initiated, Jazz Pharmaceuticals Initiated, WEX Initiated and more…
RJ Hamster
Advertisements
Ratings changes for CrowdStrike, CrowdStrike, Barrett Business Services, Meta Platforms, Mind Medicine (MindMed), Nurix Therapeutics, Merus and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
Meta Platforms (NASDAQ:META) had its price target raised by analysts at Raymond James () from $525.00 to $550.00. They now have a “strong-buy” rating on the stock. This represents a 12.9% upside from the current price of $487.09.
CMO Takeshi Numoto sold 322 shares of the company’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $416.60, for a total transaction of $134,145.20. Following the completion of the sale, the chief marketing officer now directly owns 47,255 shares of the company’s stock, valued at $19,686,433. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
CMO Takeshi Numoto sold 244 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $415.53, for a total value of $101,389.32. Following the transaction, the chief marketing officer now owns 47,011 shares in the company, valued at approximately $19,534,480.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $185.00 price target on the stock. This represents a 12.4% upside from the current price of $164.65.
Applied Materials (NASDAQ:AMAT) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $225.00 price target on the stock, up previously from $165.00. This represents a 1.1% upside from the current price of $222.52.
Maplebear (NASDAQ:CART) was upgraded by analysts at Gordon Haskett from a “hold” rating to a “buy” rating. They now have a $45.00 price target on the stock, up previously from $37.00. This represents a 46.9% upside from the current price of $30.63.
Hyster-Yale Materials Handling (NYSE:HY) was upgraded by analysts at Northland Securities from a “market perform” rating to an “outperform” rating. They now have a $90.00 price target on the stock. This represents a 27.3% upside from the current price of $70.71.
KLA (NASDAQ:KLAC) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $765.00 price target on the stock, up previously from $630.00. This represents a 1.5% downside from the current price of $776.76.
Boston Beer (NYSE:SAM) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $290.00 price target on the stock. This represents a 5.1% downside from the current price of $305.61.
Smith & Nephew (NYSE:SNN) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $26.22.
UnitedHealth Group (NYSE:UNH) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $580.00 price target on the stock. This represents a 15.1% upside from the current price of $503.76.
Discover 2024’s AI Investment Front-Runners! 🌟 (ad)
Are you eager to know which AI stocks will dominate in 2024? We’ve pinpointed the top 3 and are thrilled to share our findings with you! Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
Barrett Business Services (NASDAQ:BBSI) was downgraded by analysts at Sidoti from a “buy” rating to a “neutral” rating. They now have a $140.00 price target on the stock. This represents a 7.1% upside from the current price of $130.72.
Medifast (NYSE:MED) was downgraded by analysts at DA Davidson from a “neutral” rating to an “underperform” rating. They now have a $17.50 price target on the stock, down previously from $25.00. This represents a 18.8% downside from the current price of $21.54.
Relmada Therapeutics (NASDAQ:RLMD) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “sell” rating. They now have a $2.00 price target on the stock, down previously from $3.00. This represents a 28.1% downside from the current price of $2.78.
Titan Machinery (NASDAQ:TITN) was downgraded by analysts at B. Riley from a “buy” rating to a “neutral” rating. They now have a $20.00 price target on the stock, down previously from $32.00. This represents a 14.4% upside from the current price of $17.48.
Energy Fuels (NYSE:UUUU) was downgraded by analysts at Roth Mkm from a “buy” rating to a “neutral” rating. They now have a $6.25 price target on the stock, down previously from $6.50. This represents a 1.0% upside from the current price of $6.19.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $31.00 price target on the stock. This represents a 22.6% upside from the current price of $25.29.
Corpay (NYSE:CPAY) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $285.00 price target on the stock. This represents a 11.0% upside from the current price of $256.67.
EVgo (NYSE:EVGO) is now covered by analysts at Benchmark Co.. They set a “buy” rating and a $3.00 price target on the stock. This represents a 48.5% upside from the current price of $2.02.
Haleon (NYSE:HLN) is now covered by analysts at Berenberg Bank. They set a “buy” rating on the stock.The current price is $8.49.
Jazz Pharmaceuticals (NASDAQ:JAZZ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $169.00 price target on the stock. This represents a 58.4% upside from the current price of $106.66.
LifeMD (NASDAQ:LFMD) is now covered by analysts at KeyCorp. They set an “overweight” rating and a $12.00 price target on the stock. This represents a 52.3% upside from the current price of $7.88.
Old Dominion Freight Line (NASDAQ:ODFL) is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $210.00 price target on the stock. This represents a 18.7% upside from the current price of $176.94.
Procore Technologies (NYSE:PCOR) is now covered by analysts at Macquarie. They set a “neutral” rating and a $70.00 price target on the stock. This represents a 7.1% upside from the current price of $65.35.
Proto Labs (NYSE:PRLB) is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $44.00 price target on the stock. This represents a 38.6% upside from the current price of $31.74.
Spire Global (NYSE:SPIR) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $13.00 price target on the stock. This represents a 29.9% upside from the current price of $10.01.
Sunoco (NYSE:SUN) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $61.00 price target on the stock. This represents a 18.9% upside from the current price of $51.30.
Silvaco Group (NASDAQ:SVCO) is now covered by analysts at B. Riley. They set a “buy” rating and a $26.00 price target on the stock. This represents a 61.8% upside from the current price of $16.07.
Usio (NASDAQ:USIO) is now covered by analysts at Litchfield Hills Research. They set a “buy” rating and a $6.00 price target on the stock. This represents a 287.1% upside from the current price of $1.55.
WEX (NYSE:WEX) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $200.00 price target on the stock. This represents a 10.2% upside from the current price of $181.51.
Xometry (NASDAQ:XMTR) is now covered by analysts at Cantor Fitzgerald. They set an “underweight” rating and a $13.00 price target on the stock. This represents a 12.3% downside from the current price of $14.82.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
